Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read More
Search Results for: genetic testing
Consortium Secures Eurostars Funding to Develop Multiomics Test for Colorectal Cancer
The aim of the consortium is to develop a blood test based on transcriptomic and epigenetic biomarkers for early detection and relapse monitoring in CRC patients.
Read MoreMyriad: NCCN Updates Professional Guidelines for Patients with Prostate Cancer
The Prolaris test from Myriad Genetics was one of only two prognostic tests for prostate cancer recommended by NCCN for the new expanded indications.
Read MoreFulgent Genetics Launches NGS Test to Detect Covid-19
Fulgent Genetics partners with MedScan Laboratory to launch one of the market’s first covid-19 tests based on next-generation sequencing technology.
Read More
HHS Supports Development of High-Throughput Molecular Diagnostic for COVID-19
A COVID-19 diagnostic designed for use on a system that can process up to 1,000 tests in 24 hours will receive advanced development support from an HHS BARDA grant.
Read More